SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-235432
Filing Date
2009-11-16
Accepted
2009-11-16 14:01:46
Documents
6
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 528898
2 CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) dex311.htm EX-31.1 9666
3 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) dex312.htm EX-31.2 9821
4 CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(B) dex321.htm EX-32.1 3593
5 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(B) dex322.htm EX-32.2 3820
6 GRAPHIC g81036g53m83.jpg GRAPHIC 10190
  Complete submission text file 0001193125-09-235432.txt   571559
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 091185507
SIC: 2834 Pharmaceutical Preparations